Results 131 to 140 of about 832,216 (359)

Prevalence and Prognostic Impact of Coronary Chronic Total Occlusions in Patients With Cardiogenic Shock

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mortality in patients with cardiogenic shock (CS) remains high despite advanced treatment strategies in CS patients, underlining the need for the identification of predictors of prognosis in CS patients. Therefore, the present study investigates the prognostic impact of coronary chronic total occlusions (CTO) in patients with CS ...
Michael Behnes, Moritz Schmidberger, Giuseppe Vadalà, Alice Moroni, Juan‐Luis Guiterrez‐Chico, Stylianos Pyxaras, Alexander Bufe, Florian Krötz, Kambis Mashayekhi, Mohamed Ayoub, Jonas Rusnak, Mohammad Abumayyaleh, Jonas Dudda, Kathrin Weidner, Ibrahim Akin, Tobias Schupp   +15 more
wiley   +1 more source

A pressão coronária (às vezes) mente. . . [PDF]

, 2018
Comment on: Comparative analysis of fractional flow reserve and instantaneous wave-free ratio: Results of a five-year registry. [Rev Port Cardiol.
Baptista, SB, Raposo, L
core   +1 more source

In-hospital mortality of patients with cardiogenic shock after acute myocardial infarction; impact of early revascularization

BMC Research Notes, 2018
The purpose of this study was to determine the frequency of in-hospital mortality in 351 patients who developed cardiogenic shock after acute myocardial infarction and by determining this; we might find that how efficiently we could manage this serious ...
K. Hashmi, Khawar Abbas, A. Hashmi, M. Irfan, Muhammad M. Edhi, N. Ali, Amir Khan   +6 more
semanticscholar   +1 more source

Comparison of Fixed‐Dose Clopidogrel/Asetylsalicylic Acid Combination and Standard Loading Strategy During Percutaneous Coronary Intervention in Chronic Coronary Syndrome

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Dual antiplatelet therapy (DAPT), comprising acetylsalicylic acid and a P2Y12 receptor inhibitor such as clopidogrel, is the cornerstone of management in patients undergoing percutaneous coronary intervention (PCI). While conventional loading doses of acetylsalicylic acid and clopidogrel are well established, there is limited ...
Ahmet Anıl Başkurt, Oktay Şenöz, Yusuf Demir, Eren Ozan Bakır, Ferhat Siyamend Yurdam, Ecem Gürses, İlhan Koyuncu, Ahmet Erseçgin, Saadet Aydın, Zeynep Yapan Emren, İlker Gül   +10 more
wiley   +1 more source

Controlled Delivery of Sdf-1 Alpha and Igf-1: Cxcr4(+) Cell Recruitment and Functional Skeletal Muscle Recovery [PDF]

, 2015
Therapeutic delivery of regeneration-promoting biological factors directly to the site of injury has demonstrated its efficacy in various injury models.
Farrar, Roger P., Hammers, David W., Hsieh, Pei-Ling, Merscham-Banda, Melissa, Pham, Chantal B., Rybalko, Viktoriya Y., Suggs, Laura J.   +6 more
core   +1 more source

CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program

Clinical Pharmacology &Therapeutics, EarlyView.
CYP2C19 loss‐of‐function (LOF) alleles decrease the antiplatelet effect of clopidogrel following percutaneous coronary intervention (PCI) in patients presenting with acute coronary syndrome (ACS). The impact of genotype in patients undergoing PCI for stable ischemic heart disease (SIHD) in real‐world populations is less clear.
Catherine Chanfreau‐Coffinier, Kevin A. Friede, Mary E. Plomondon, Kyung Min Lee, Zhenyu Lu, Tia Dinatale, Scott L. DuVall, Jason L. Vassy, Stephen W. Waldo, John H. Cleator, Thomas M. Maddox, Daniel J. Rader, Themistocles L. Assimes, Scott M. Damrauer, Philip S. Tsao, Kyong‐Mi Chang, Deepak Voora, Julie A. Lynch, Jay Giri, VA Million Veteran Program, Sony Tuteja   +20 more
wiley   +1 more source

Effectiveness and Safety of Reduced‐Dose Prasugrel in an East Asian Population: PRASFIT‐ACS Emulation Using National Health Insurance Claims Data

Clinical Pharmacology &Therapeutics, EarlyView.
Prasugrel is recommended for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). However, East Asians exhibit a stronger antiplatelet response, raising concerns about bleeding risks with standard dosing. This retrospective cohort study evaluated the real‐world effectiveness and safety of reduced‐dose prasugrel in
Li‐Wen Huang, Yee‐Jen Wu, Fang‐Ju Lin, Chien‐Chih Wu, Hsin‐Yi Huang, Chi‐Chuan Wang, Xiaojuan Li   +6 more
wiley   +1 more source

Scintigraphy assessment of ischemic myocardial viability in patients with post-infarction left ventricular aneurysm

Российский кардиологический журнал, 2007
The study included 15patients with coronary heart disease (CHD), post-infarction cardiosclerosis, and chronic left ventricular (LV) aneurysm. All patients underwent interventional myocardial revascularization and Dor aneurysmectomy.
E. V. Makarova, S. M. Minin, V. I. Chernov, E. V. Krivoshchekov, Yu. V. Lishmanov   +4 more
doaj  

Updated Strategies in Non-Culprit Stenosis Management of Multivessel Coronary Disease—A Contemporary Review

Medicina
The prevalence of multivessel coronary artery disease (CAD) in acute coronary syndrome (ACS) patients underscores the need for optimal revascularization strategies.
Rares-Dumitru Manuca, Alexandra Maria Covic, Crischentian Brinza, Mariana Floria, Cristian Statescu, Adrian Covic, Alexandru Burlacu   +6 more
doaj   +1 more source

Prospective study one-year clinical outcomes of the Calypso coronary stent in patients presenting with acute coronary syndrome

Патология кровообращения и кардиохирургия, 2017
Aim. To evaluate the effectiveness of the stent use Calypso Angiolain Russia with primary percutaneous transluminal coronary angioplasty (PTCA).Methods. The study prospectively included 150 patients who underwent PTCA in acute coronary syndrome (ACS) for
В. Л. Воробьев, А. А. Семенихин, Н. И. Грачев, В. В. Верин   +3 more
doaj   +1 more source